PCM Encore’s Colgate-Palmolive CL Stock Holding History

PCM Encore’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$312K	Sell	3,408 -60	-2%	-$5.25K	0.05%	318
2026 Q1	$296K	Buy	3,468 +356	+11%	+$31.7K	0.06%	311
2025 Q4	$246K	Buy	+3,112	New	+$244K	0.05%	357

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PCM Encore's CL Position: Q2 2026 in Review

PCM Encore reduced its Colgate-Palmolive (CL) stake by 1.7% in Q2 2026, selling an estimated $5.25K and leaving 3,408 shares worth $312K. The position accounts for 0.05% of the portfolio, ranked #318.

PCM Encore first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

PCM Encore held 3,408 shares of Colgate-Palmolive worth $312K as of Q2 2026.
PCM Encore sold 60 Colgate-Palmolive shares in Q2 2026, an estimated $5.25K.
Colgate-Palmolive made up 0.05% of PCM Encore's portfolio in Q2 2026, its #318 holding.
PCM Encore first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.